Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

Autor: Gattermann, N. Finelli, C. Della Porta, M. Fenaux, P. Ganser, A. Guerci-Bresler, A. Schmid, M. Taylor, K. Vassilieff, D. Habr, D. Domokos, G. Roubert, B. Rose, C. Agaoglu, L. Alimena, G. Alonso, D. Ame, S. Angelucci, E. Arrizabalaga, B. Athanasiou-Metaxa, M. Augustson, B. Aydinok, Y. Baba, A. Baccarani, M. Beck, J. Beris, P. Beyne-Rauzy, O. Birgens, H. Bordessoule, D. Borgna-Pignatti, C. Bosly, A. Bouabdallah, K. Bowden, D. Bowen, D. Bron, D. Cappellini, M.D. Capra, M. Cartron, G. Cazzola, M. Chalkias, C. Chan, L.L. Chancharunee, S. Chapman, C. Charoenkwan, P. Chasapopoulou, E. Cheze, S. Chuansumrit, A. Cianciulli, P. Dauriac, C. Delforge, M. Dölken, G. Dombret, H. Duyster, J. Economopoulos, T. Ehninger, G. Elalfy, M. El-Beshlawy, A. Enggaard, L. Fillet, G. Filosa, A. Forni, G. Galanello, R. Gastl, G. Giraudier, S. Goldfarb, A. Grigg, A. Gumruk, F. Ha, S.Y. Haase, D. Heinrich, B. Hertzberg, M. Ho, J. Hsu, H.-C. Huang, S. Hunault-Berger, M. Inusa, B. Jaulmes, D. Jensen, J. Kattamis, A. Kilinc, Y. Kim, K.-H. Kinsey, S. Kjeldsen, L. Koren, A. Lai, M.E. Lai, Y. Lee, J.-W. Lee, K.-H. Lee, S.-H. Legros, L. Li, C. Li, C.-K. Li, Q. Lin, K.-H. Linkesch, W. Lübbert, M. Lutz, D. Mohamed Thalha, A.J. Mufti, G. Muus, P. Nobile, F. Papadopoulos, N. Perrotta, S. Petrini, M. Pfeilstöcker, M. Piga, A. Poole, J. Porter, J.B. Pungolino, E. Quarta, G. Ravoet, C. Jolimont Lobbes, H.H. Remacha, A.F. Roy, L. Saglio, G. Sanz, G. Schmugge, M. Schots, H. Secchi, G. Seymour, J.F. Shah, F. Shah, H. Shen, Z. Slama, B. Sutcharitchan, P. Taher, A. Tamary, H. Tesch, H.-J. Thein, S.L. Troncy, J. Villegas, A. Viprakasit, V. Wainwright, L. Wassmann, B. Wettervald, M. Will, A. Wörmann, B. Wright, J. Yeh, S.-P. Yoon, S.-S. Zoumbos, N.C. Zweegman, S.

The prospective 1-year EPIC study enrolled 341 patients with myelodysplastic syndromes (MDS); although baseline iron burden was >2500. ng/mL, ∼50% were chelation-naïve. Overall median serum ferritin decreased significantly at 1 year (p=0.002). Dec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::5f53441e8c70c8aaff95c8727c5d14eb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089133

Simulation of the effects of anaerobic or mature biofilms on the crevice corrosion behaviour of stainless steels in natural marine environment

Autor: Mollica A., Montini U., Lai M.E., Féron D.

Publikováno v: EUROCORR 2003, Budapest, 2003
info:cnr-pdr/source/autori:Mollica A., Montini U., Lai M.E., Féron D./congresso_nome:EUROCORR 2003/congresso_luogo:Budapest/congresso_data:2003/anno:2003/pagina_da:/pagina_a:/intervallo_pagine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::4024f20a8f3556c9b8692328c8458993
http://www.cnr.it/prodotto/i/93806

F-51 Virological response and HBV-DNA reduction during therapy with peginterferon alpha-2a (PEG-IFNα-2a) in patients affected by HBeAg-negative chronic hepatitis B

Autor: Chessa, L., Serra, G., Balestrieri, C., Conti, M., Pasetto, M.C., Iovine, M., Cappellini, S., Casu, S., Casale, M., Figorilli, F., Onali, S., Lai, M.E., Farci, P.

Publikováno v: In Digestive and Liver Disease February 2012 44 Supplement 1:S48-S48

Direct electrochemistry of catalase on glassy carbon electrodes

Autor: Lai, M.E.¹, Bergel, A. bergel@chimie.ups-tlse.fr

Publikováno v: Bioelectrochemistry. Jan2002, Vol. 55 Issue 1/2, p157. 4p.

F-7 Insulin resistance does not affect sustained virologic response in patients with chronic hepatitis C without cirrhosis treated with peg-interferon alfa 2a and ribavirin

Autor: Chessa, L., Serra, G., Balestrieri, C., Conti, M., Casale, M., Calabrò, C., Cappellini, S., Casu, S., Iovine, M., Cossu, E., Lai, M.E., Farci, P.

Publikováno v: In Digestive and Liver Disease 2011 43 Supplement 2:S94-S94